English and Spanish
(800) CDC-INFO
(800) 232-4636
TTY: (888) 232-6348
FAX: (770) 488-4760

International Travel
Phone: 1-887-394-8747
email: cdcinfo@cdc.gov

Active Bacterial Core Surveillance (ABCs)
A Core Component of the Emerging Infections Program

 Links

	CDC's Active Bacterial Core Surveillance (ABCs) http://www.cdc.gov/abcs
	Group A streptococcal disease for all audiences http://www.cdc.gov/ncidod/dbmd/diseaseinfo/groupastreptococcal_g.htm
	Group B streptococcal disease http://www.cdc.gov/groupbstrep
	Pneumococcal disease http://www.cdc.gov/ncidod/dbmd/diseaseinfo/streppneum_t.htm
	Antibiotic resistance http://www.cdc.gov/drugresistance/community/
	Meningococcal disease http://www.cdc.gov/ncidod/dbmd/diseaseinfo/meningococcal_g.htm
	Haemophilus influenzae Serotype b (Hib) disease http://www.cdc.gov/ncidod/dbmd/diseaseinfo/haeminfluserob_t.htm

 References

Whitney CG, Farley MM, Hadler J, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. New Engl J Med 2003; 348(18): 1737-1746.

Pinner RW, Rebmann CA, Schuchat A, Hughes JM. Disease surveillance and the academic, clinical, and public health communities. Emerg Infect Dis 2003; 9(7): 781-787

Schrag SJ, Zell ER, Lynfield R, et al. A population-based comparison of strategies to prevent early onset group B streptococcal disease in neonates. New Engl J Med 2002; 347: 233-239.

Ohuabunwo C, Bath S, Bisgard K, Murphy T, Shutt K, Rosenstein N. Progress toward elimination of Haemophilus influenzae Type b invasive disease among infants and children, United States, 1998--2000. MMWR 2002; 51(11); 234-237.

O'Brien K, Beall B, Barrett NL, et al. Epidemiology of invasive group A streptococcus disease in the United States, 1995-1999. Clin Infect Dis 2002; 35: 268-276.

Lingappa JR, Rosenstein N, Zell ER, et al. Surveillance for meningococcal disease and strategies for use of conjugate meningococcal vaccines in the United States. Vaccine 2001; 19(31): 4566-4575.